A study of cytohistological correlation of equivocal or atypical proliferative breast lesions at a tertiary care institution of North India


  • Raman Kapil Department of Pathology, PGIMS, Rohtak, Haryana, India
  • Meenu Gill Department of Pathology, PGIMS, Rohtak, Haryana, India
  • Sucheta Malik Department of Pathology, PGIMS, Rohtak, Haryana, India http://orcid.org/0000-0002-7738-268X
  • Lalit Singh Department of Pathology, PGIMS, Rohtak, Haryana, India
  • Sumiti Gupta Department of Pathology, PGIMS, Rohtak, Haryana, India
  • Rajeev Sen Department of Pathology, PGIMS, Rohtak, Haryana, India




Breast carcinoma, FNAC, Grey zone lesions


Background: Fine needle aspiration cytology is the mostly the first diagnostic test used for the diagnosis of breast masses. But there is morphological overlap among the sequential lesions from the precancerous group to frank carcinoma known as “grey zone”. This grey zone in cytology is estimated to constitute 8.9% of cases.

Methods: Smears were prepared from the fine needle aspirates and stained with Leishman/Giemsa. Trucut biopsy, mastectomy or MRM specimens of patients diagnosed as having on cytology benign with atypia (C3) /suspicious of malignancy (C4) were subjected to histopathological evaluation and cytohistopathogical correlation was done in these cases.

Results: 75% of patients who belonged to category C3 had benign lesions, whereas about 90% of those in category C4 had malignant diagnosis. This difference was statistically significant.

Conclusions: Combination of the mammography and cytology along with the clinical findings (the "triple test") allows for proper management for each patient, determining which patient should undergo surgery and which patient needs close follow-up, hence avoiding an unnecessary surgery. And the patients in cytology category C4 must have the diagnosis confirmed by histological examination.


Lester SC. The breast. In: Kumar V, Abbas AK, Fausto N, editors. Robbins and Cotran Pathologic basis of disease. 8th ed. Philadelphia: Elsevier Saunders; 2010; 1065-95.

Van Diest PJ, Risse EK, Schipper NW, Baak JP, Mouriquand J. Comparison of light microscopic grading and morphometric features in cytological breast cancer specimens. Pathol Res Pract. 1989; 185:612-6.

Al-Kaisi N. The spectrum of the "gray zone" in breast cytology: a review of 186 cases of atypical and suspicious cytology. Acta Cytol. 1994;38:898-908.

Denley H, Pinder SE, Elston CW, Lee AH, Ellis IO. Preoperative assessment of prognostic factors in breast cancer. J Clin Pathol. 2001;54:20-4.

Das AK, Kapila K, Dinda AK, Verma K. Comparative evaluation of grading of breast carcinomas in fine needle aspirates by two methods. Indian J Med Res. 2003;118:247-50.

Ezzeldeen MM, Hussein H. Conservative Breast Surgery and Fine Needle Aspiration Cytology: Implications In Equivocal Cases (The Grey Zone). Kasr El Aini J Sur. 2007;8:81-91.

Shabb NS, Boulos FI, Abdul-Karim FW. Indeterminate and erroneous FNA of breast with focus on the ‘true gray zone’: a review. Acta Cytol. 2013;57:316-31.

Rosai J. Breast. In: Rosai J, editor. Rosai and Ackerman’s Surgical Pathology. 10th ed. Missouri: Mosby; 2011:1659-770.

Benign breast tumors and conditions. Available at: http://www.imaginis.com/breast-health–non-cancerous/benign-breast-conditions-1. Accessed on 20 November 2021.

Rabban JT, Sgroi DC. Sclerosing lesions of the breast. Semin Diagn Pathol. 2004;21:42-7.

Guray M, Sahin AA. Benign breast diseases: classification, diagnosis and management. Oncologist. 2006;11:435-49.

Breast Cancer. Available at: http://en.wikipedia. org/wiki/Breast-cancer. Accessed on 20 November 2021.

Ellis IO, Pinder SE, Lee AHS. Tumors of the breast. In: Fletcher CDM, eds. Diagnostic Histopathology of Tumors. 4th ed. Philadelphia: Churchill Livingstone; 2013:1057-145.

Bagchi S. Breast cancer rises in India. Canadian Med Assn J. 2008;179:27.

Takiar R, Srivastav A. Time trend in breast and cervix cancer of women in India-(1990-2003). Asian Pac J Cancer Prev. 2008;9:777-80.

Guidelines for Nonoperative diagnostic procedures and reporting in breast cancer screening. Available at: https://www.rcpath.org/ uploads/assets/4b16f19c-f7bd-456c-b212f557f8040f66/G150-Non-op-reporting-breast-cancer-screening.pdf. Accessed on 20 November 2021.

Sinha R, Anderson DE, McDonald SS, Greenwald P. Cancer risk and diet in India. J Postgrad Med. 2003;49:222-8.

Breast fine needle aspiration cytology and core biopsy: a guide for practice. in edited by department of health and ageing. Available at: https://www.canceraustralia.gov.au/sites/default/files/publications/fna-fine-needle-aspiration-cytology-and-core-biopsy-guide-for-practice_504af03 488799.pdf. Accessed on 20 November 2021.

Connolly JL, Jacobs TW. The Breast. In: Silverberg SG, DeLellis RA, Frable WJ, Livolsi VA, Wick MR, eds. Silverberg’s principles and practice of surgical cytopathology. 4th ed. Philadelphia: Churchill Livingstone; 2006:419-504.

Dutta SK, Chattopadhyaya A, Roy S. Fine needle aspiration and imprint cytology in the diagnosis of breast lesions with histopathological correlation. J Ind Med Assoc. 2001;99:421-3.

Chaiwun B, Sukhamwang N, Lekawanvijit S, Sukapan K, Rangdaeng S, Muttarak M et al. Atypical and suspicious categories in fine needle aspiration cytology of the breast: histological and mammographical correlation and clinical significance. Singapore Med J. 2005;46:706-9.

National accreditiation board for hospitals and healthcare providers bio medical waste management, rules. Available at: http://nabh.co/announce-ment/bmw_rules_2016.pdf. Accessed on 20 November 2021.

Boerner S, Sneige N. Specimen adequacy and false negative diagnosis rate in fine needle aspirates of palpable breast masses. Cancer. 1998;84(6):344-8.

Ellis IO, Humphreys S, Michell M, Pinder SE, Wells CA, Zakhour HD, et al. Best Practice No 179: Guidelines for breast needle core biopsy handling and reporting in breast screening assessment. J Clinical Pathol. 2004;57(9):897-902.

Arul P, Masilamani S, Akshatha C. Fine needle aspiration cytology of atypical (C3) and suspicious (C4) categories in the breast and its histopathologic correlation. J Cytol. 2016;33:76-9.

Madan M, Sharma M, Piplani S, Manjari M, Sharma N, Goyal S. Evaluation of Fine Needle Aspiration Cytology in the Diagnosis of Suspicious/gray Zone Lesions in Breast Lesions and its Histopathological Correlation. Anna Pathol Lab Med. Dec; 2016;3(6): 573-6.

Goyal P, Sehgal S, Ghosh S, Aggarwal D, Shukla P, Kumar A, et al. Histopathological correlation of Atypica; (C3) and Suspicious (C4) categories in Fine Needle Aspiration Cytology of the breast. Int J Breast Cancer. 2013;2013:965498.

Vandana G, Magar SLR, Anil S, Rani S. Atypical and suspicious categories in fine needle aspiration cytology of the breast: histopathological and mammographical correlation with clinical significance. J Den Med Sci. 2016;15(3):57-61.

Yusuf I, Atanda AT, Imam MI. Cyto-morphologic correlation of equivocal C3 and C4 breast lesions. Arch Int Surg. 2014;4:131-5.

Chaiwun B, Settakorn J, Ya-In C, Wisedmongkol W, Rangdaeng S, Thorner P, et al. Effectiveness of fine-needle aspiration cytology of breast: analysis of 2,375 cases from northern Thailand. Diagn Cytopathol. 2002;26:201-5.




How to Cite

Kapil, R., Gill, M., Malik, S., Singh, L., Gupta, S., & Sen, R. (2022). A study of cytohistological correlation of equivocal or atypical proliferative breast lesions at a tertiary care institution of North India. International Journal of Research in Medical Sciences, 10(2), 444–450. https://doi.org/10.18203/2320-6012.ijrms20220290



Original Research Articles